1. Kerangka reasesmen
Sebagian obat sudah tercantum di Formularium Nasional tetapi hanya dijamin di fasilitas kesehatan rujukan tingkat lanjut (FKRTL). Apabila penyakitnya ditangani di fasilitas kesehatan tingkat pertama (FKTP), pasien harus dirujuk hanya untuk memperoleh obat. Reasesmen menanyakan obat mana yang layak dibuka untuk diresepkan di FKTP.
ARC Institute mengidentifikasi 396 obat yang hanya dijamin di FKRTL dan mengurutkannya menurut kapasitas medis layanan primer: fasilitas yang diwajibkan menuntaskan suatu penyakit semestinya dapat meresepkan obatnya.
| Reasesmen 1 | Hanya dijamin di FKRTL, padahal digunakan untuk salah satu dari 144 penyakit yang wajib dituntaskan dokter di FKTP. Dokter layanan primer wajib menangani penyakitnya tetapi tidak dapat meresepkan obatnya. | 98 obat |
|---|---|---|
| Reasesmen 2 | Hanya dijamin di FKRTL dan termasuk obat Program Rujuk Balik, yaitu untuk pasien kronik stabil yang dikembalikan ke layanan primer. | 18 obat |
| Reasesmen 3 | Hanya dijamin di FKRTL dan tercantum dalam Daftar Obat Esensial WHO, atau sudah memiliki penilaian teknologi kesehatan. | 161 obat |
| Reasesmen 4 | Hanya dijamin di FKRTL, tanpa penanda di atas. Masih memerlukan telaah klinis. | 119 obat |
Sumber: analisis ARC Institute atas Formularium Nasional, data izin edar BPOM, katalog elektronik pengadaan pemerintah, Daftar Obat Esensial WHO, dan penilaian teknologi NICE.
2. Penilaian dalam program reasesmen
Penilaian berikut disusun khusus untuk pertanyaan akses di layanan primer.
| Judul | Nomor rujukan | Status | Usulan |
|---|---|---|---|
| Aripiprazol untuk skizofrenia stabil dalam layanan bersamaSistem saraf | PTK-N05AX12 | Draf untuk telaah | Belum dapat direkomendasikan |
| Klopidogrel untuk pencegahan sekunder penyakit kardiovaskular aterosklerotikDarah dan organ pembentuk darah | PTK-B01AC04 | Draf untuk telaah | Diusulkan untuk direkomendasikan |
| Pioglitazon untuk diabetes melitus tipe 2 yang belum terkendali dengan metforminSaluran cerna dan metabolisme | PTK-A10BG03 | Draf untuk telaah | Belum dapat direkomendasikan |
| Rosuvastatin untuk pencegahan sekunder penyakit kardiovaskularSistem kardiovaskular | PTK-C10AA07 | Draf untuk telaah | Diusulkan untuk direkomendasikan |
| Salmeterol dan flutikason untuk terapi pengontrol asmaSistem pernapasan | PTK-R03AK06 | Draf untuk telaah | Perlu pertimbangan komite |
| DapagliflozinSaluran cerna dan metabolisme | PTK-A10BK01 | Dalam pengembangan | Belum tersedia |
| Formoterol dan budesonideSistem pernapasan | PTK-R03AK07 | Dalam pengembangan | Belum tersedia |
| GliclazideSaluran cerna dan metabolisme | PTK-A10BB09 | Dalam pengembangan | Belum tersedia |
| MetforminSaluran cerna dan metabolisme | PTK-A10BA02 | Dalam pengembangan | Belum tersedia |
| RivaroxabanDarah dan organ pembentuk darah | PTK-B01AF01 | Dalam pengembangan | Belum tersedia |
| Telmisartan dan diureticsSistem kardiovaskular | PTK-C09DA07 | Dalam pengembangan | Belum tersedia |
| Tiotropium bromideSistem pernapasan | PTK-R03BB04 | Dalam pengembangan | Belum tersedia |
3. Daftar kandidat perluasan
Menampilkan 396 dari 396 obat
| Obat | Kode ATC | Tingkat | Penyakit yang wajib dituntaskan di FKTP | Penanda | Penilaian |
|---|---|---|---|---|---|
| EsomeprazolSaluran cerna dan metabolisme | A02BC05 | Reasesmen 1 | Gastritis (K29) | - | Draf untuk telaah Belum dapat direkomendasikan |
| Formoterol dan budesonideSistem pernapasan | R03AK07 | Reasesmen 1 | Asma bronkial (J45) | Program Rujuk Balik, WHO | Dalam pengembangan |
| GliclazideSaluran cerna dan metabolisme | A10BB09 | Reasesmen 1 | Diabetes melitus tipe 2 (E11) | Program Rujuk Balik, WHO | Dalam pengembangan |
| PioglitazonSaluran cerna dan metabolisme | A10BG03 | Reasesmen 1 | Diabetes melitus tipe 2 (E11) | Program Rujuk Balik | Draf untuk telaah Belum dapat direkomendasikan |
| RamiprilSistem kardiovaskular | C09AA05 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Draf untuk telaah Diusulkan untuk direkomendasikan |
| RosuvastatinSistem kardiovaskular | C10AA07 | Reasesmen 1 | Dislipidemia (R79) | Program Rujuk Balik | Draf untuk telaah Diusulkan untuk direkomendasikan |
| Salmeterol dan flutikasonSistem pernapasan | R03AK06 | Reasesmen 1 | Asma bronkial (J45) | Program Rujuk Balik | Draf untuk telaah Perlu pertimbangan komite |
| AbacavirAntiinfeksi sistemik | J05AF06 | Reasesmen 1 | HIV AIDS tanpa komplikasi (B20) | WHO | Belum dimulai |
| AciclovirOrgan indra | S01AD03 | Reasesmen 1 | Herpes simpleks tanpa komplikasi (B00) | WHO | Belum dimulai |
| AlprazolamSistem saraf | N05BA12 | Reasesmen 1 | Insomnia (G47) | - | Belum dimulai |
| Amoxicillin dan beta-lactamase inhibitorAntiinfeksi sistemik | J01CR02 | Reasesmen 1 | Tonsilitis (J03) | WHO | Belum dimulai |
| Amphotericin BSaluran cerna dan metabolisme | A01AB04 | Reasesmen 1 | Kandidiasis mulut (B37) | WHO | Belum dimulai |
| Artificial tears dan other indifferent preparationsOrgan indra | S01XA20 | Reasesmen 1 | Mata kering (H04) | - | Belum dimulai |
| AtropineOrgan indra | S01FA01 | Reasesmen 1 | Hipermetropia ringan / Miopia ringan / Astigmatism ringan (H52) | WHO | Belum dimulai |
| AzithromycinAntiinfeksi sistemik | J01FA10 | Reasesmen 1 | Faringitis (J02) | WHO | Belum dimulai |
| BetamethasoneOrgan indra | S01BA06 | Reasesmen 1 | Konjungtivitis (H10) | WHO | Belum dimulai |
| CandesartanSistem kardiovaskular | C09CA06 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Belum dimulai |
| CarvedilolSistem kardiovaskular | C07AG02 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik, WHO | Belum dimulai |
| CefalexinAntiinfeksi sistemik | J01DB01 | Reasesmen 1 | Impetigo (L01) | WHO | Belum dimulai |
| CefiximeAntiinfeksi sistemik | J01DD08 | Reasesmen 1 | Gonore (A54) | WHO | Belum dimulai |
| CeftriaxoneAntiinfeksi sistemik | J01DD04 | Reasesmen 1 | Gonore (A54) | WHO | Belum dimulai |
| CefuroximeAntiinfeksi sistemik | J01DC02 | Reasesmen 1 | Otitis media akut (H67) | WHO | Belum dimulai |
| ChloroquineAntiparasit | P01BA01 | Reasesmen 1 | Malaria (B54) | WHO | Belum dimulai |
| CisaprideSaluran cerna dan metabolisme | A03FA02 | Reasesmen 1 | Refluks gastroesofagus (K21) | - | Belum dimulai |
| ClarithromycinAntiinfeksi sistemik | J01FA09 | Reasesmen 1 | Pneumonia, bronkopneumonia (J18) | WHO | Belum dimulai |
| ClobazamSistem saraf | N05BA09 | Reasesmen 1 | Kejang demam (R56) | - | Belum dimulai |
| ClonazepamSistem saraf | N03AE01 | Reasesmen 1 | Kejang demam (R56) | WHO | Belum dimulai |
| ClonidineSistem kardiovaskular | C02AC01 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Belum dimulai |
| ColecalciferolSaluran cerna dan metabolisme | A11CC05 | Reasesmen 1 | Defisiensi vitamin (E56) | WHO | Belum dimulai |
| ColestyramineSistem kardiovaskular | C10AC01 | Reasesmen 1 | Dislipidemia (R79) | - | Belum dimulai |
| CyclopentolateOrgan indra | S01FA04 | Reasesmen 1 | Hipermetropia ringan / Miopia ringan / Astigmatism ringan (H52) | WHO | Belum dimulai |
| DesoximetasoneDermatologi | D07AC03 | Reasesmen 1 | Dermatitis atopik (L20) | - | Belum dimulai |
| DiltiazemSistem kardiovaskular | C08DB01 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Belum dimulai |
| DoxazosinSistem kardiovaskular | C02CA04 | Reasesmen 1 | Hipertensi esensial (I10) | - | Belum dimulai |
| Emtricitabine, tenofovir disoproxil dan efavirenzAntiinfeksi sistemik | J05AR06 | Reasesmen 1 | HIV AIDS tanpa komplikasi (B20) | WHO | Belum dimulai |
| EthambutolAntiinfeksi sistemik | J04AK02 | Reasesmen 1 | Tuberkulosis paru tanpa komplikasi (A15) | WHO | Belum dimulai |
| FebuxostatSistem muskuloskeletal | M04AA03 | Reasesmen 1 | Hiperurisemia (E79) | - | Belum dimulai |
| FenofibrateSistem kardiovaskular | C10AB05 | Reasesmen 1 | Dislipidemia (R79) | - | Belum dimulai |
| Fenoterol dan ipratropium bromideSistem pernapasan | R03AL01 | Reasesmen 1 | Asma bronkial (J45) | Program Rujuk Balik | Belum dimulai |
| Fixed dose combination (FDC) contains paraffin, glycerin, dan phenolphthaleinSistem kardiovaskular | C05A | Reasesmen 1 | Hemoroid grade 1/2 (I84) | - | Belum dimulai |
| FluconazoleAntiinfeksi sistemik | J02AC01 | Reasesmen 1 | Kandidiasis mulut (B37) | WHO | Belum dimulai |
| FluorometholoneOrgan indra | S01BA07 | Reasesmen 1 | Konjungtivitis (H10) | - | Belum dimulai |
| Fluticasone furoateSistem pernapasan | R03BA09 | Reasesmen 1 | Asma bronkial (J45) | - | Belum dimulai |
| Fusidic acidDermatologi | D06AX01 | Reasesmen 1 | Impetigo (L01) | - | Belum dimulai |
| Fusidic acidOrgan indra | S01AA13 | Reasesmen 1 | Konjungtivitis (H10) | - | Belum dimulai |
| GemfibrozilSistem kardiovaskular | C10AB04 | Reasesmen 1 | Dislipidemia (R79) | - | Belum dimulai |
| GliquidoneSaluran cerna dan metabolisme | A10BB08 | Reasesmen 1 | Diabetes melitus tipe 2 (E11) | Program Rujuk Balik | Belum dimulai |
| HomatropineOrgan indra | S01FA05 | Reasesmen 1 | Hipermetropia ringan / Miopia ringan / Astigmatism ringan (H52) | WHO | Belum dimulai |
| ImidaprilSistem kardiovaskular | C09AA16 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Belum dimulai |
| Insulin (human)Saluran cerna dan metabolisme | A10AB01 | Reasesmen 1 | Diabetes melitus tipe 1 (E10) | Program Rujuk Balik | Belum dimulai |
| Insulin (human)Saluran cerna dan metabolisme | A10AD01 | Reasesmen 1 | Diabetes melitus tipe 2 (E11) | Program Rujuk Balik | Belum dimulai |
| Insulin aspartSaluran cerna dan metabolisme | A10AB05 | Reasesmen 1 | Diabetes melitus tipe 1 (E10) | Program Rujuk Balik, WHO | Belum dimulai |
| Insulin aspartSaluran cerna dan metabolisme | A10AD05 | Reasesmen 1 | Diabetes melitus tipe 2 (E11) | Program Rujuk Balik, WHO | Belum dimulai |
| Insulin glulisineSaluran cerna dan metabolisme | A10AB06 | Reasesmen 1 | Diabetes melitus tipe 1 (E10) | Program Rujuk Balik, WHO | Belum dimulai |
| Insulin lisproSaluran cerna dan metabolisme | A10AB04 | Reasesmen 1 | Diabetes melitus tipe 1 (E10) | Program Rujuk Balik, WHO | Belum dimulai |
| Insulin lisproSaluran cerna dan metabolisme | A10AD04 | Reasesmen 1 | Diabetes melitus tipe 2 (E11) | Program Rujuk Balik, WHO | Belum dimulai |
| IrbesartanSistem kardiovaskular | C09CA04 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Belum dimulai |
| ItraconazoleAntiinfeksi sistemik | J02AC02 | Reasesmen 1 | Tinea unguium (B35) | WHO | Belum dimulai |
| KetorolacSistem muskuloskeletal | M01AB15 | Reasesmen 1 | Tension headache (G44) | - | Belum dimulai |
| LansoprazoleSaluran cerna dan metabolisme | A02BC03 | Reasesmen 1 | Gastritis (K29) | - | Belum dimulai |
| LevofloxacinAntiinfeksi sistemik | J01MA12 | Reasesmen 1 | Pneumonia, bronkopneumonia (J18) | WHO | Belum dimulai |
| LevofloxacinOrgan indra | S01AE05 | Reasesmen 1 | Konjungtivitis (H10) | WHO | Belum dimulai |
| LoperamideSaluran cerna dan metabolisme | A07DA03 | Reasesmen 1 | Gastroenteritis (termasuk kolera, giardiasis) (A09) | WHO | Belum dimulai |
| Metamizole sodiumSistem saraf | N02BB02 | Reasesmen 1 | Tension headache (G44) | - | Belum dimulai |
| MetoprololSistem kardiovaskular | C07AB02 | Reasesmen 1 | Hipertensi esensial (I10) | WHO | Belum dimulai |
| MetronidazoleAntiinfeksi sistemik | J01XD01 | Reasesmen 1 | Vaginosis bakterialis (N76) | WHO | Belum dimulai |
| MidazolamSistem saraf | N05CD08 | Reasesmen 1 | Kejang demam (R56) | WHO | Belum dimulai |
| MinocyclineAntiinfeksi sistemik | J01AA08 | Reasesmen 1 | Akne vulgaris ringan (L70) | - | Belum dimulai |
| MoxifloxacinOrgan indra | S01AE07 | Reasesmen 1 | Konjungtivitis (H10) | WHO | Belum dimulai |
| MupirocinDermatologi | D06AX09 | Reasesmen 1 | Impetigo (L01) | WHO | Belum dimulai |
| NicardipineSistem kardiovaskular | C08CA04 | Reasesmen 1 | Hipertensi esensial (I10) | - | Belum dimulai |
| NifedipineSistem kardiovaskular | C08CA05 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik, WHO | Belum dimulai |
| OfloxacinAntiinfeksi sistemik | J01MA01 | Reasesmen 1 | Infeksi saluran kemih bagian bawah (N39) | WHO | Belum dimulai |
| OfloxacinOrgan indra | S02AA16 | Reasesmen 1 | Otitis eksterna (H60) | WHO | Belum dimulai |
| OndansetronSaluran cerna dan metabolisme | A04AA01 | Reasesmen 1 | Gastroenteritis (termasuk kolera, giardiasis) (A09) | WHO | Belum dimulai |
| OxymetazolineOrgan indra | S01GA04 | Reasesmen 1 | Konjungtivitis (H10) | - | Belum dimulai |
| OxytetracyclineAntiinfeksi sistemik | J01AA06 | Reasesmen 1 | Akne vulgaris ringan (L70) | WHO | Belum dimulai |
| PerindoprilSistem kardiovaskular | C09AA04 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Belum dimulai |
| PhenylephrineOrgan indra | S01FB01 | Reasesmen 1 | Konjungtivitis (H10) | - | Belum dimulai |
| Pipemidic acidAntiinfeksi sistemik | J01MB04 | Reasesmen 1 | Infeksi saluran kemih bagian bawah (N39) | - | Belum dimulai |
| PravastatinSistem kardiovaskular | C10AA03 | Reasesmen 1 | Dislipidemia (R79) | WHO | Belum dimulai |
| PrednisoloneOrgan indra | S01BA04 | Reasesmen 1 | Episkleritis (H15) | WHO | Belum dimulai |
| ProcaterolSistem pernapasan | R03AC16 | Reasesmen 1 | Asma bronkial (J45) | - | Belum dimulai |
| ProcaterolSistem pernapasan | R03CC08 | Reasesmen 1 | Asma bronkial (J45) | - | Belum dimulai |
| PyrazinamideAntiinfeksi sistemik | J04AK01 | Reasesmen 1 | Tuberkulosis paru tanpa komplikasi (A15) | WHO | Belum dimulai |
| RetinolOrgan indra | S01XA02 | Reasesmen 1 | Buta senja (E50) | WHO | Belum dimulai |
| SitagliptinSaluran cerna dan metabolisme | A10BH01 | Reasesmen 1 | Diabetes melitus tipe 2 (E11) | Program Rujuk Balik | Belum dimulai |
| SucralfateSaluran cerna dan metabolisme | A02BX02 | Reasesmen 1 | Gastritis (K29) | - | Belum dimulai |
| TelmisartanSistem kardiovaskular | C09CA07 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Belum dimulai |
| TerbinafineDermatologi | D01BA02 | Reasesmen 1 | Tinea unguium (B35) | WHO | Belum dimulai |
| TheophyllineSistem pernapasan | R03DA04 | Reasesmen 1 | Asma bronkial (J45) | Program Rujuk Balik | Belum dimulai |
| TobramycinOrgan indra | S01AA12 | Reasesmen 1 | Konjungtivitis (H10) | WHO | Belum dimulai |
| TramadolSistem saraf | N02AX02 | Reasesmen 1 | Vulnus laseratum, punctum (T00) | WHO | Belum dimulai |
| TriamcinoloneSaluran cerna dan metabolisme | A01AC01 | Reasesmen 1 | Ulkus mulut (aptosa, herpes) (K12) | - | Belum dimulai |
| ValaciclovirAntiinfeksi sistemik | J05AB11 | Reasesmen 1 | Herpes zoster tanpa komplikasi (B02) | WHO | Belum dimulai |
| ValsartanSistem kardiovaskular | C09CA03 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik | Belum dimulai |
| VerapamilSistem kardiovaskular | C08DA01 | Reasesmen 1 | Hipertensi esensial (I10) | Program Rujuk Balik, WHO | Belum dimulai |
| VildagliptinSaluran cerna dan metabolisme | A10BH02 | Reasesmen 1 | Diabetes melitus tipe 2 (E11) | Program Rujuk Balik | Belum dimulai |
| AripiprazolSistem saraf | N05AX12 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Draf untuk telaah Belum dapat direkomendasikan |
| KlopidogrelDarah dan organ pembentuk darah | B01AC04 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Draf untuk telaah Diusulkan untuk direkomendasikan |
| AmiodaroneSistem kardiovaskular | C01BD01 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| CalcitriolSaluran cerna dan metabolisme | A11CC04 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| CilostazolDarah dan organ pembentuk darah | B01AC23 | Reasesmen 2 | - | Program Rujuk Balik | Belum dimulai |
| ClozapineSistem saraf | N05AH02 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| DigoxinSistem kardiovaskular | C01AA05 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| FluvoxamineSistem saraf | N06AB08 | Reasesmen 2 | - | Program Rujuk Balik | Belum dimulai |
| HydroxychloroquineAntiparasit | P01BA02 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| IndacaterolSistem pernapasan | R03AC18 | Reasesmen 2 | - | Program Rujuk Balik | Belum dimulai |
| OlanzapineSistem saraf | N05AH03 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| OlodaterolSistem pernapasan | R03AC19 | Reasesmen 2 | - | Program Rujuk Balik | Belum dimulai |
| Olodaterol dan tiotropium bromideSistem pernapasan | R03AL06 | Reasesmen 2 | - | Program Rujuk Balik | Belum dimulai |
| OxcarbazepineSistem saraf | N03AF02 | Reasesmen 2 | - | Program Rujuk Balik | Belum dimulai |
| PaliperidoneSistem saraf | N05AX13 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| QuetiapineSistem saraf | N05AH04 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| SertralineSistem saraf | N06AB06 | Reasesmen 2 | - | Program Rujuk Balik | Belum dimulai |
| WarfarinDarah dan organ pembentuk darah | B01AA03 | Reasesmen 2 | - | Program Rujuk Balik, WHO | Belum dimulai |
| DonepezilSistem saraf | N06DA02 | Reasesmen 3 | - | WHO | Dalam pengembangan |
| EntecavirAntiinfeksi sistemik | J05AF10 | Reasesmen 3 | - | WHO | Dalam pengembangan |
| ErythropoietinDarah dan organ pembentuk darah | B03XA01 | Reasesmen 3 | - | WHO | Dalam pengembangan |
| Methoxy polyethylene glycol-epoetin betaDarah dan organ pembentuk darah | B03XA03 | Reasesmen 3 | - | WHO | Dalam pengembangan |
| RanibizumabOrgan indra | S01LA04 | Reasesmen 3 | - | WHO | Draf untuk telaah Diusulkan untuk direkomendasikan |
| RituximabAntineoplastik dan imunomodulator | L01FA01 | Reasesmen 3 | - | WHO | Dalam pengembangan |
| RivaroxabanDarah dan organ pembentuk darah | B01AF01 | Reasesmen 3 | - | WHO | Dalam pengembangan |
| TikagrelorDarah dan organ pembentuk darah | B01AC24 | Reasesmen 3 | - | WHO | Draf untuk telaah Diusulkan untuk direkomendasikan |
| TrastuzumabAntineoplastik dan imunomodulator | L01FD01 | Reasesmen 3 | - | WHO | Draf untuk telaah Diusulkan dengan syarat |
| AfatinibAntineoplastik dan imunomodulator | L01EB03 | Reasesmen 3 | - | WHO | Belum dimulai |
| AlprostadilSistem kardiovaskular | C01EA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| AlteplaseDarah dan organ pembentuk darah | B01AD02 | Reasesmen 3 | - | WHO | Belum dimulai |
| AmikacinAntiinfeksi sistemik | J01GB06 | Reasesmen 3 | - | WHO | Belum dimulai |
| Amphotericin BAntiinfeksi sistemik | J02AA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| AnastrozoleAntineoplastik dan imunomodulator | L02BG03 | Reasesmen 3 | - | WHO | Belum dimulai |
| Anti-D (rh) immunoglobulinAntiinfeksi sistemik | J06BB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| AsparaginaseAntineoplastik dan imunomodulator | L01XX02 | Reasesmen 3 | - | WHO | Belum dimulai |
| AtracuriumSistem muskuloskeletal | M03AC04 | Reasesmen 3 | - | WHO | Belum dimulai |
| AzathioprineAntineoplastik dan imunomodulator | L04AX01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Barium sulfate with suspending agentsLain-lain | V08BA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| BedaquilineAntiinfeksi sistemik | J04AK05 | Reasesmen 3 | - | WHO | Belum dimulai |
| BendamustineAntineoplastik dan imunomodulator | L01AA09 | Reasesmen 3 | - | WHO | Belum dimulai |
| BicalutamideAntineoplastik dan imunomodulator | L02BB03 | Reasesmen 3 | - | WHO | Belum dimulai |
| BleomycinAntineoplastik dan imunomodulator | L01DC01 | Reasesmen 3 | - | WHO | Belum dimulai |
| BortezomibAntineoplastik dan imunomodulator | L01XG01 | Reasesmen 3 | - | WHO | Belum dimulai |
| BromocriptineSistem genitourinaria dan hormon seks | G02CB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| BupivacaineSistem saraf | N01BB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| CaffeineSistem saraf | N06BC01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Calcium folinateLain-lain | V03AF03 | Reasesmen 3 | - | WHO | Belum dimulai |
| CapecitabineAntineoplastik dan imunomodulator | L01BC06 | Reasesmen 3 | - | WHO | Belum dimulai |
| CarbimazoleHormon sistemik | H03BB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| CarboplatinAntineoplastik dan imunomodulator | L01XA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| CefazolinAntiinfeksi sistemik | J01DB04 | Reasesmen 3 | - | WHO | Belum dimulai |
| CefepimeAntiinfeksi sistemik | J01DE01 | Reasesmen 3 | - | WHO | Belum dimulai |
| CefotaximeAntiinfeksi sistemik | J01DD01 | Reasesmen 3 | - | WHO | Belum dimulai |
| CeftazidimeAntiinfeksi sistemik | J01DD02 | Reasesmen 3 | - | WHO | Belum dimulai |
| ChlorambucilAntineoplastik dan imunomodulator | L01AA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| CiclosporinAntineoplastik dan imunomodulator | L04AD01 | Reasesmen 3 | - | WHO | Belum dimulai |
| CisplatinAntineoplastik dan imunomodulator | L01XA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| ClotrimazoleSistem genitourinaria dan hormon seks | G01AF02 | Reasesmen 3 | - | WHO | Belum dimulai |
| Coagulation factor IXDarah dan organ pembentuk darah | B02BD04 | Reasesmen 3 | - | WHO | Belum dimulai |
| Coagulation factor VIIIDarah dan organ pembentuk darah | B02BD02 | Reasesmen 3 | - | WHO | Belum dimulai |
| CyclophosphamideAntineoplastik dan imunomodulator | L01AA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| CytarabineAntineoplastik dan imunomodulator | L01BC01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Dabigatran etexilateDarah dan organ pembentuk darah | B01AE07 | Reasesmen 3 | - | WHO | Belum dimulai |
| DacarbazineAntineoplastik dan imunomodulator | L01AX04 | Reasesmen 3 | - | WHO | Belum dimulai |
| DaclatasvirAntiinfeksi sistemik | J05AP07 | Reasesmen 3 | - | WHO | Belum dimulai |
| DactinomycinAntineoplastik dan imunomodulator | L01DA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| DaunorubicinAntineoplastik dan imunomodulator | L01DB02 | Reasesmen 3 | - | WHO | Belum dimulai |
| DeferasiroxLain-lain | V03AC03 | Reasesmen 3 | - | WHO | Belum dimulai |
| DeferiproneLain-lain | V03AC02 | Reasesmen 3 | - | WHO | Belum dimulai |
| DeferoxamineLain-lain | V03AC01 | Reasesmen 3 | - | WHO | Belum dimulai |
| DelamanidAntiinfeksi sistemik | J04AK06 | Reasesmen 3 | - | WHO | Belum dimulai |
| DesmopressinHormon sistemik | H01BA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| Diatrizoic acidLain-lain | V08AA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Diphtheria antitoxinAntiinfeksi sistemik | J06AA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| DocetaxelAntineoplastik dan imunomodulator | L01CD02 | Reasesmen 3 | - | WHO | Belum dimulai |
| DopamineSistem kardiovaskular | C01CA04 | Reasesmen 3 | - | WHO | Belum dimulai |
| ElectrolytesDarah dan organ pembentuk darah | B05BB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| EnoxaparinDarah dan organ pembentuk darah | B01AB05 | Reasesmen 3 | - | WHO | Belum dimulai |
| EphedrineSistem kardiovaskular | C01CA26 | Reasesmen 3 | - | WHO | Belum dimulai |
| ErlotinibAntineoplastik dan imunomodulator | L01EB02 | Reasesmen 3 | - | WHO | Belum dimulai |
| EtanerceptAntineoplastik dan imunomodulator | L04AB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| EtoposideAntineoplastik dan imunomodulator | L01CB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| EverolimusAntineoplastik dan imunomodulator | L01EG02 | Reasesmen 3 | - | WHO | Belum dimulai |
| FentanylSistem saraf | N01AH01 | Reasesmen 3 | - | WHO | Belum dimulai |
| FentanylSistem saraf | N02AB03 | Reasesmen 3 | - | WHO | Belum dimulai |
| FilgrastimAntineoplastik dan imunomodulator | L03AA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| FludarabineAntineoplastik dan imunomodulator | L01BB05 | Reasesmen 3 | - | WHO | Belum dimulai |
| FludrocortisoneHormon sistemik | H02AA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| FluorouracilAntineoplastik dan imunomodulator | L01BC02 | Reasesmen 3 | - | WHO | Belum dimulai |
| FulvestrantAntineoplastik dan imunomodulator | L02BA03 | Reasesmen 3 | - | WHO | Belum dimulai |
| GefitinibAntineoplastik dan imunomodulator | L01EB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Gelatin agentsDarah dan organ pembentuk darah | B05AA06 | Reasesmen 3 | - | WHO | Belum dimulai |
| GemcitabineAntineoplastik dan imunomodulator | L01BC05 | Reasesmen 3 | - | WHO | Belum dimulai |
| GentamicinAntiinfeksi sistemik | J01GB03 | Reasesmen 3 | - | WHO | Belum dimulai |
| GlycopyrroniumDermatologi | D11AA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| GoserelinAntineoplastik dan imunomodulator | L02AE03 | Reasesmen 3 | - | WHO | Belum dimulai |
| HeparinDarah dan organ pembentuk darah | B01AB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Hyaluronic acidDermatologi | D03AX05 | Reasesmen 3 | - | WHO | Belum dimulai |
| HydromorphoneSistem saraf | N02AA03 | Reasesmen 3 | - | WHO | Belum dimulai |
| HydroxycarbamideAntineoplastik dan imunomodulator | L01XX05 | Reasesmen 3 | - | WHO | Belum dimulai |
| IbuprofenSistem kardiovaskular | C01EB16 | Reasesmen 3 | - | WHO | Belum dimulai |
| IfosfamideAntineoplastik dan imunomodulator | L01AA06 | Reasesmen 3 | - | WHO | Belum dimulai |
| ImatinibAntineoplastik dan imunomodulator | L01EA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Immunoglobulins, normal human, for intravascular adm.Antiinfeksi sistemik | J06BA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| IohexolLain-lain | V08AB02 | Reasesmen 3 | - | WHO | Belum dimulai |
| IrinotecanAntineoplastik dan imunomodulator | L01CE02 | Reasesmen 3 | - | WHO | Belum dimulai |
| IsofluraneSistem saraf | N01AB06 | Reasesmen 3 | - | WHO | Belum dimulai |
| KetamineSistem saraf | N01AX03 | Reasesmen 3 | - | WHO | Belum dimulai |
| LamotrigineSistem saraf | N03AX09 | Reasesmen 3 | - | WHO | Belum dimulai |
| LatanoprostOrgan indra | S01EE01 | Reasesmen 3 | - | WHO | Belum dimulai |
| LenalidomideAntineoplastik dan imunomodulator | L04AX04 | Reasesmen 3 | - | WHO | Belum dimulai |
| LenvatinibAntineoplastik dan imunomodulator | L01EX08 | Reasesmen 3 | - | WHO | Belum dimulai |
| LetrozoleAntineoplastik dan imunomodulator | L02BG04 | Reasesmen 3 | - | WHO | Belum dimulai |
| LeuprorelinAntineoplastik dan imunomodulator | L02AE02 | Reasesmen 3 | - | WHO | Belum dimulai |
| LevetiracetamSistem saraf | N03AX14 | Reasesmen 3 | - | WHO | Belum dimulai |
| Levodopa dan decarboxylase inhibitorSistem saraf | N04BA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| Levothyroxine sodiumHormon sistemik | H03AA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| LithiumSistem saraf | N05AN01 | Reasesmen 3 | - | WHO | Belum dimulai |
| MannitolSaluran cerna dan metabolisme | A06AD16 | Reasesmen 3 | - | WHO | Belum dimulai |
| MedroxyprogesteroneSistem genitourinaria dan hormon seks | G03DA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| MelphalanAntineoplastik dan imunomodulator | L01AA03 | Reasesmen 3 | - | WHO | Belum dimulai |
| MercaptopurineAntineoplastik dan imunomodulator | L01BB02 | Reasesmen 3 | - | WHO | Belum dimulai |
| MeropenemAntiinfeksi sistemik | J01DH02 | Reasesmen 3 | - | WHO | Belum dimulai |
| MesalazineSaluran cerna dan metabolisme | A07EC02 | Reasesmen 3 | - | WHO | Belum dimulai |
| MesnaSistem pernapasan | R05CB05 | Reasesmen 3 | - | WHO | Belum dimulai |
| MethotrexateAntineoplastik dan imunomodulator | L04AX03 | Reasesmen 3 | - | WHO | Belum dimulai |
| MethylphenidateSistem saraf | N06BA04 | Reasesmen 3 | - | WHO | Belum dimulai |
| MetronidazoleSistem genitourinaria dan hormon seks | G01AF01 | Reasesmen 3 | - | WHO | Belum dimulai |
| MicafunginAntiinfeksi sistemik | J02AX05 | Reasesmen 3 | - | WHO | Belum dimulai |
| MorphineSistem saraf | N02AA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| MoxifloxacinAntiinfeksi sistemik | J01MA14 | Reasesmen 3 | - | WHO | Belum dimulai |
| NadroparinDarah dan organ pembentuk darah | B01AB06 | Reasesmen 3 | - | WHO | Belum dimulai |
| NaloxoneSaluran cerna dan metabolisme | A06AH04 | Reasesmen 3 | - | WHO | Belum dimulai |
| NatamycinOrgan indra | S01AA10 | Reasesmen 3 | - | WHO | Belum dimulai |
| Natural phospholipidsSistem pernapasan | R07AA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| NeostigmineSistem saraf | N07AA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| NilotinibAntineoplastik dan imunomodulator | L01EA03 | Reasesmen 3 | - | WHO | Belum dimulai |
| Nitrous oxideSistem saraf | N01AX13 | Reasesmen 3 | - | WHO | Belum dimulai |
| NorethisteroneSistem genitourinaria dan hormon seks | G03DC02 | Reasesmen 3 | - | WHO | Belum dimulai |
| OctreotideHormon sistemik | H01CB02 | Reasesmen 3 | - | WHO | Belum dimulai |
| OxaliplatinAntineoplastik dan imunomodulator | L01XA03 | Reasesmen 3 | - | WHO | Belum dimulai |
| OxycodoneSistem saraf | N02AA05 | Reasesmen 3 | - | WHO | Belum dimulai |
| PaclitaxelAntineoplastik dan imunomodulator | L01CD01 | Reasesmen 3 | - | WHO | Belum dimulai |
| PegaspargaseAntineoplastik dan imunomodulator | L01XX24 | Reasesmen 3 | - | WHO | Belum dimulai |
| PodophyllotoxinDermatologi | D06BB04 | Reasesmen 3 | - | WHO | Belum dimulai |
| PramipexoleSistem saraf | N04BC05 | Reasesmen 3 | - | WHO | Belum dimulai |
| PropofolSistem saraf | N01AX10 | Reasesmen 3 | - | WHO | Belum dimulai |
| PropylthiouracilHormon sistemik | H03BA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| ProtamineLain-lain | V03AB14 | Reasesmen 3 | - | WHO | Belum dimulai |
| PyridostigmineSistem saraf | N07AA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| PyrimethamineAntiparasit | P01BD01 | Reasesmen 3 | - | WHO | Belum dimulai |
| RopiniroleSistem saraf | N04BC04 | Reasesmen 3 | - | WHO | Belum dimulai |
| SevofluraneSistem saraf | N01AB08 | Reasesmen 3 | - | WHO | Belum dimulai |
| Silver nitrateDermatologi | D08AL01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Sodium chlorideSaluran cerna dan metabolisme | A12CA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| SofosbuvirAntiinfeksi sistemik | J05AP08 | Reasesmen 3 | - | WHO | Belum dimulai |
| Sofosbuvir dan velpatasvirAntiinfeksi sistemik | J05AP55 | Reasesmen 3 | - | WHO | Belum dimulai |
| SomatropinHormon sistemik | H01AC01 | Reasesmen 3 | - | WHO | Belum dimulai |
| StreptokinaseDarah dan organ pembentuk darah | B01AD01 | Reasesmen 3 | - | WHO | Belum dimulai |
| SulfadiazineAntiinfeksi sistemik | J01EC02 | Reasesmen 3 | - | WHO | Belum dimulai |
| SulfasalazineSaluran cerna dan metabolisme | A07EC01 | Reasesmen 3 | - | WHO | Belum dimulai |
| SulfurDermatologi | D10AB02 | Reasesmen 3 | - | WHO | Belum dimulai |
| SuxamethoniumSistem muskuloskeletal | M03AB01 | Reasesmen 3 | - | WHO | Belum dimulai |
| TacrolimusAntineoplastik dan imunomodulator | L04AD02 | Reasesmen 3 | - | WHO | Belum dimulai |
| TamoxifenAntineoplastik dan imunomodulator | L02BA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| Technetium (99mTc) succimerLain-lain | V09CA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| TemozolomideAntineoplastik dan imunomodulator | L01AX03 | Reasesmen 3 | - | WHO | Belum dimulai |
| Tenofovir alafenamideAntiinfeksi sistemik | J05AF13 | Reasesmen 3 | - | WHO | Belum dimulai |
| TestosteroneSistem genitourinaria dan hormon seks | G03BA03 | Reasesmen 3 | - | WHO | Belum dimulai |
| ThiamazoleHormon sistemik | H03BB02 | Reasesmen 3 | - | WHO | Belum dimulai |
| ThiopentalSistem saraf | N01AF03 | Reasesmen 3 | - | WHO | Belum dimulai |
| TocilizumabAntineoplastik dan imunomodulator | L04AC07 | Reasesmen 3 | - | WHO | Belum dimulai |
| ValganciclovirAntiinfeksi sistemik | J05AB14 | Reasesmen 3 | - | WHO | Belum dimulai |
| VancomycinAntiinfeksi sistemik | J01XA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| VinblastineAntineoplastik dan imunomodulator | L01CA01 | Reasesmen 3 | - | WHO | Belum dimulai |
| VincristineAntineoplastik dan imunomodulator | L01CA02 | Reasesmen 3 | - | WHO | Belum dimulai |
| VinorelbineAntineoplastik dan imunomodulator | L01CA04 | Reasesmen 3 | - | WHO | Belum dimulai |
| VoriconazoleAntiinfeksi sistemik | J02AC03 | Reasesmen 3 | - | WHO | Belum dimulai |
| Zoledronic acidSistem muskuloskeletal | M05BA08 | Reasesmen 3 | - | WHO | Belum dimulai |
| AdenosineSistem kardiovaskular | C01EB10 | Reasesmen 4 | - | - | Belum dimulai |
| AlbuminDarah dan organ pembentuk darah | B05AA01 | Reasesmen 4 | - | - | Belum dimulai |
| AlectinibAntineoplastik dan imunomodulator | L01ED03 | Reasesmen 4 | - | - | Belum dimulai |
| Alendronic acidSistem muskuloskeletal | M05BA04 | Reasesmen 4 | - | - | Belum dimulai |
| Amino acidsDarah dan organ pembentuk darah | B05BA01 | Reasesmen 4 | - | - | Belum dimulai |
| Ampicillin dan beta-lactamase inhibitorAntiinfeksi sistemik | J01CR01 | Reasesmen 4 | - | - | Belum dimulai |
| BasiliximabAntineoplastik dan imunomodulator | L04AC02 | Reasesmen 4 | - | - | Belum dimulai |
| BeraprostDarah dan organ pembentuk darah | B01AC19 | Reasesmen 4 | - | - | Belum dimulai |
| BetaxololOrgan indra | S01ED02 | Reasesmen 4 | - | - | Belum dimulai |
| Brentuximab vedotinAntineoplastik dan imunomodulator | L01FX05 | Reasesmen 4 | - | - | Belum dimulai |
| BrinzolamideOrgan indra | S01EC04 | Reasesmen 4 | - | - | Belum dimulai |
| BusulfanAntineoplastik dan imunomodulator | L01AB01 | Reasesmen 4 | - | - | Belum dimulai |
| Cardioplegia solutionsDarah dan organ pembentuk darah | B05XA | Reasesmen 4 | - | - | Belum dimulai |
| CefoperazoneAntiinfeksi sistemik | J01DD12 | Reasesmen 4 | - | - | Belum dimulai |
| Cefoperazone dan beta-lactamase inhibitorAntiinfeksi sistemik | J01DD62 | Reasesmen 4 | - | - | Belum dimulai |
| CefpiromeAntiinfeksi sistemik | J01DE02 | Reasesmen 4 | - | - | Belum dimulai |
| CelecoxibSistem muskuloskeletal | M01AH01 | Reasesmen 4 | - | - | Belum dimulai |
| CetuximabAntineoplastik dan imunomodulator | L01FE01 | Reasesmen 4 | - | - | Belum dimulai |
| Chloral hydrateSistem saraf | N05CC01 | Reasesmen 4 | - | - | Belum dimulai |
| ClobetasolDermatologi | D07AD01 | Reasesmen 4 | - | - | Belum dimulai |
| Clodronic acidSistem muskuloskeletal | M05BA02 | Reasesmen 4 | - | - | Belum dimulai |
| Coagulation factor VIIDarah dan organ pembentuk darah | B02BD05 | Reasesmen 4 | - | - | Belum dimulai |
| Coagulation factor XDarah dan organ pembentuk darah | B02BD13 | Reasesmen 4 | - | - | Belum dimulai |
| CombinationsDarah dan organ pembentuk darah | B05BA10 | Reasesmen 4 | - | - | Belum dimulai |
| Conjugated estrogensSistem genitourinaria dan hormon seks | G03CA57 | Reasesmen 4 | - | - | Belum dimulai |
| DesfluraneSistem saraf | N01AB07 | Reasesmen 4 | - | - | Belum dimulai |
| DesogestrelSistem genitourinaria dan hormon seks | G03AC09 | Reasesmen 4 | - | - | Belum dimulai |
| Desogestrel dan ethinylestradiolSistem genitourinaria dan hormon seks | G03AA09 | Reasesmen 4 | - | - | Belum dimulai |
| DexmedetomidineSistem saraf | N05CM18 | Reasesmen 4 | - | - | Belum dimulai |
| DienogestSistem genitourinaria dan hormon seks | G03DB08 | Reasesmen 4 | - | - | Belum dimulai |
| DiflucortoloneDermatologi | D07AC06 | Reasesmen 4 | - | - | Belum dimulai |
| DobutamineSistem kardiovaskular | C01CA07 | Reasesmen 4 | - | - | Belum dimulai |
| DutasterideSistem genitourinaria dan hormon seks | G04CB02 | Reasesmen 4 | - | - | Belum dimulai |
| EltrombopagDarah dan organ pembentuk darah | B02BX05 | Reasesmen 4 | - | - | Belum dimulai |
| EpirubicinAntineoplastik dan imunomodulator | L01DB03 | Reasesmen 4 | - | - | Belum dimulai |
| EribulinAntineoplastik dan imunomodulator | L01XX41 | Reasesmen 4 | - | - | Belum dimulai |
| EscitalopramSistem saraf | N06AB10 | Reasesmen 4 | - | - | Belum dimulai |
| ExemestaneAntineoplastik dan imunomodulator | L02BG06 | Reasesmen 4 | - | - | Belum dimulai |
| Fat emulsionsDarah dan organ pembentuk darah | B05BA02 | Reasesmen 4 | - | - | Belum dimulai |
| FinasterideSistem genitourinaria dan hormon seks | G04CB01 | Reasesmen 4 | - | - | Belum dimulai |
| Fixed Dose Combination (FDC) contains sofosbuvir dan daclatasvirAntiinfeksi sistemik | J05AP | Reasesmen 4 | - | - | Belum dimulai |
| Fludeoxyglucose (18F)Lain-lain | V09IX04 | Reasesmen 4 | - | - | Belum dimulai |
| Fluocinolone acetonideDermatologi | D07AC04 | Reasesmen 4 | - | - | Belum dimulai |
| FondaparinuxDarah dan organ pembentuk darah | B01AX05 | Reasesmen 4 | - | - | Belum dimulai |
| GadobutrolLain-lain | V08CA09 | Reasesmen 4 | - | - | Belum dimulai |
| Gadoteric acidLain-lain | V08CA02 | Reasesmen 4 | - | - | Belum dimulai |
| Gadoxetic acidLain-lain | V08CA10 | Reasesmen 4 | - | - | Belum dimulai |
| GalactoseLain-lain | V04CE01 | Reasesmen 4 | - | - | Belum dimulai |
| GanciclovirAntiinfeksi sistemik | J05AB06 | Reasesmen 4 | - | - | Belum dimulai |
| HemodialysisDarah dan organ pembentuk darah | B05ZA | Reasesmen 4 | - | - | Belum dimulai |
| Ibandronic acidSistem muskuloskeletal | M05BA06 | Reasesmen 4 | - | - | Belum dimulai |
| IdarubicinAntineoplastik dan imunomodulator | L01DB06 | Reasesmen 4 | - | - | Belum dimulai |
| IloprostDarah dan organ pembentuk darah | B01AC11 | Reasesmen 4 | - | - | Belum dimulai |
| Indacaterol dan glycopyrronium bromideSistem pernapasan | R03AL04 | Reasesmen 4 | - | - | Belum dimulai |
| Interferon alfa-2aAntineoplastik dan imunomodulator | L03AB04 | Reasesmen 4 | - | - | Belum dimulai |
| Iobenguane (131I)Lain-lain | V10XA02 | Reasesmen 4 | - | - | Belum dimulai |
| IodixanolLain-lain | V08AB09 | Reasesmen 4 | - | - | Belum dimulai |
| IopamidolLain-lain | V08AB04 | Reasesmen 4 | - | - | Belum dimulai |
| IopromideLain-lain | V08AB05 | Reasesmen 4 | - | - | Belum dimulai |
| IvabradineSistem kardiovaskular | C01EB17 | Reasesmen 4 | - | - | Belum dimulai |
| LapatinibAntineoplastik dan imunomodulator | L01EH01 | Reasesmen 4 | - | - | Belum dimulai |
| LeflunomideAntineoplastik dan imunomodulator | L04AK01 | Reasesmen 4 | - | - | Belum dimulai |
| LenograstimAntineoplastik dan imunomodulator | L03AA10 | Reasesmen 4 | - | - | Belum dimulai |
| Levodopa, decarboxylase inhibitor dan COMT inhibitorSistem saraf | N04BA03 | Reasesmen 4 | - | - | Belum dimulai |
| MacrogolSaluran cerna dan metabolisme | A06AD15 | Reasesmen 4 | - | - | Belum dimulai |
| MaprotilineSistem saraf | N06AA21 | Reasesmen 4 | - | - | Belum dimulai |
| MilrinoneSistem kardiovaskular | C01CE02 | Reasesmen 4 | - | - | Belum dimulai |
| MitomycinAntineoplastik dan imunomodulator | L01DC03 | Reasesmen 4 | - | - | Belum dimulai |
| Mycophenolic acidAntineoplastik dan imunomodulator | L04AA06 | Reasesmen 4 | - | - | Belum dimulai |
| NimodipineSistem kardiovaskular | C08CA06 | Reasesmen 4 | - | - | Belum dimulai |
| NomegestrolSistem genitourinaria dan hormon seks | G03DB04 | Reasesmen 4 | - | - | Belum dimulai |
| NorepinephrineSistem kardiovaskular | C01CA03 | Reasesmen 4 | - | - | Belum dimulai |
| PazopanibAntineoplastik dan imunomodulator | L01EX03 | Reasesmen 4 | - | - | Belum dimulai |
| PemetrexedAntineoplastik dan imunomodulator | L01BA04 | Reasesmen 4 | - | - | Belum dimulai |
| Peritoneal dialysisDarah dan organ pembentuk darah | B05DB | Reasesmen 4 | - | - | Belum dimulai |
| PethidineSistem saraf | N02AB02 | Reasesmen 4 | - | - | Belum dimulai |
| PhenylephrineSistem kardiovaskular | C01CA06 | Reasesmen 4 | - | - | Belum dimulai |
| PolicresulenSistem genitourinaria dan hormon seks | G01AX03 | Reasesmen 4 | - | - | Belum dimulai |
| Polystyrene sulfonateLain-lain | V03AE01 | Reasesmen 4 | - | - | Belum dimulai |
| PonatinibAntineoplastik dan imunomodulator | L01EA05 | Reasesmen 4 | - | - | Belum dimulai |
| Potassium aspartateSaluran cerna dan metabolisme | A12BA | Reasesmen 4 | - | - | Belum dimulai |
| PregabalinSistem saraf | N02BF02 | Reasesmen 4 | - | - | Belum dimulai |
| RemdesivirAntiinfeksi sistemik | J05AB16 | Reasesmen 4 | - | - | Belum dimulai |
| RemifentanilSistem saraf | N01AH06 | Reasesmen 4 | - | - | Belum dimulai |
| Risedronic acidSistem muskuloskeletal | M05BA07 | Reasesmen 4 | - | - | Belum dimulai |
| Rocuronium bromideSistem muskuloskeletal | M03AC09 | Reasesmen 4 | - | - | Belum dimulai |
| RopivacaineSistem saraf | N01BB09 | Reasesmen 4 | - | - | Belum dimulai |
| RuxolitinibAntineoplastik dan imunomodulator | L01EJ01 | Reasesmen 4 | - | - | Belum dimulai |
| Saccharated iron oxideDarah dan organ pembentuk darah | B03AB02 | Reasesmen 4 | - | - | Belum dimulai |
| Samarium (153Sm) lexidronamLain-lain | V10BX02 | Reasesmen 4 | - | - | Belum dimulai |
| SecukinumabAntineoplastik dan imunomodulator | L04AC10 | Reasesmen 4 | - | - | Belum dimulai |
| SevelamerLain-lain | V03AE02 | Reasesmen 4 | - | - | Belum dimulai |
| SildenafilSistem genitourinaria dan hormon seks | G04BE03 | Reasesmen 4 | - | - | Belum dimulai |
| SilodosinSistem genitourinaria dan hormon seks | G04CA04 | Reasesmen 4 | - | - | Belum dimulai |
| Sodium edetateOrgan indra | S01XA05 | Reasesmen 4 | - | - | Belum dimulai |
| Sodium iodide (131I)Lain-lain | V10XA01 | Reasesmen 4 | - | - | Belum dimulai |
| Sodium phosphateSaluran cerna dan metabolisme | A06AD17 | Reasesmen 4 | - | - | Belum dimulai |
| SolifenacinSistem genitourinaria dan hormon seks | G04BD08 | Reasesmen 4 | - | - | Belum dimulai |
| Solution contains fat-soluble vitamins (vitamins A, D, E, K)Darah dan organ pembentuk darah | B05XC | Reasesmen 4 | - | - | Belum dimulai |
| SomatostatinHormon sistemik | H01CB01 | Reasesmen 4 | - | - | Belum dimulai |
| SpiramycinAntiinfeksi sistemik | J01FA02 | Reasesmen 4 | - | - | Belum dimulai |
| SufentanilSistem saraf | N01AH03 | Reasesmen 4 | - | - | Belum dimulai |
| SugammadexLain-lain | V03AB35 | Reasesmen 4 | - | - | Belum dimulai |
| TamsulosinSistem genitourinaria dan hormon seks | G04CA02 | Reasesmen 4 | - | - | Belum dimulai |
| Technetium (99mTc) macrosalbLain-lain | V09EB01 | Reasesmen 4 | - | - | Belum dimulai |
| Technetium (99mTc) mertiatideLain-lain | V09CA03 | Reasesmen 4 | - | - | Belum dimulai |
| Technetium (99mTc) oxidronic acidLain-lain | V09BA01 | Reasesmen 4 | - | - | Belum dimulai |
| Technetium (99mTc) pentetic acidLain-lain | V09CA01 | Reasesmen 4 | - | - | Belum dimulai |
| Technetium (99mTc) pertechnetateLain-lain | V09FX01 | Reasesmen 4 | - | - | Belum dimulai |
| Technetium (99mTc) sestamibiLain-lain | V09GA01 | Reasesmen 4 | - | - | Belum dimulai |
| TelbivudineAntiinfeksi sistemik | J05AF11 | Reasesmen 4 | - | - | Belum dimulai |
| TerazosinSistem genitourinaria dan hormon seks | G04CA03 | Reasesmen 4 | - | - | Belum dimulai |
| Timolol, combinationsOrgan indra | S01ED51 | Reasesmen 4 | - | - | Belum dimulai |
| TopiramateSistem saraf | N03AX11 | Reasesmen 4 | - | - | Belum dimulai |
| TravoprostOrgan indra | S01EE04 | Reasesmen 4 | - | - | Belum dimulai |
| TrometamolDarah dan organ pembentuk darah | B05BB03 | Reasesmen 4 | - | - | Belum dimulai |
| Ursodeoxycholic acidSaluran cerna dan metabolisme | A05AA02 | Reasesmen 4 | - | - | Belum dimulai |
| Vasopressin (argipressin)Hormon sistemik | H01BA01 | Reasesmen 4 | - | - | Belum dimulai |
| ZonisamideSistem saraf | N03AX15 | Reasesmen 4 | - | - | Belum dimulai |
Tidak ada yang cocok. Ubah kata kunci atau hapus salah satu saringan.